Recognition of normal, neoplastic, and fetal airway epithelial cell membranes by two monoclonal antibodies

Human Pathology

Volumn 28, Issue 7, 1997, Pages 840-846

  Strayer, David S ^a   Schwarting, Roland ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bronchus; Fetal lung antigens; Gene therapy; Non small cell lung carcinoma; SPA; Type II cells

Indexed keywords

IDIOTYPIC ANTIBODY; LUNG SURFACTANT; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; FETUS; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; RECEPTOR BINDING; RESPIRATORY EPITHELIUM;

EID: 0030856570     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90159-3     Document Type: Article

References (28)

1. Kuroki Y, Mason RJ, Voelker DR: Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc Natl Acad Sci U S A 85:5566-5570, 1988
2. Rice WR, Ross GF, Singleton FM, et al: Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 63:692-698, 1987
3. Strayer DS: Identification of a cell membrane protein that binds alveolar surfactant. Am J Pathol 138:1085-1095, 1991
4. Strayer DS, Yang SJ, Jerng HH: Surfactant protein A binding proteins: Characterization and structures. J Biol Chem 268:18679-18684, 1993
5. Strayer DS, Finder BS, Chander A: Receptor-mediated regulation of pulmonary surfactant secretion. Exptl Cell Res 226:90-97, 1996
6. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
7. Lichtenberger LM, Graziani LA, Dial EJ, et al: Role of surface-active phospholipids in gastric cytoprotection. Science 219:1327-1329, 1983
8. De Schryver-Kecskemeti K, Eliakim R, Carroll S, et al: Intestinal surfactant-like material. J Clin Invest 84:1355-1361, 1989
9. Brezicka FT, Oiling S: L3p40-50-a new lung tumor-associated 40- to 50-kDa antigen defined by a monoclonal antibody (L3). Intl J Cancer 8 (suppl):121-124, 1994
10. Smith LH, Yin A, Glasky MS, et al: Human monoclonal antibody recognizing an antigen associated with ovarian and other adenocarcinomas. Am J Obstet Gynecol 166:634-645, 1992
11. Yonezawa S, Tachikawa T, Shin S, et al: Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas. Am J Clin Pathol 98:167-174, 1992
12. Nouwen EJ, Dauwe S, DeBroe ME: Occurrence of the mucinous differentiation antigen CA125 in genital tract and conductive airway epithelia of diverse mammalian species (rabbit, dog, monkey). Differentiation 45:192-198, 1990
13. Gulowsen AC, Myrseth LE, Brandtzaeg P, et al: A monoclonal antibody to a megakaryoblast-like cell line detects a protein found in blood cells and in the epithelial cell lining of various rat tissues. Eur J Cell Biol 52:142-146, 1990
14. Dippold WG, Klingel R, Bernhard H, et al: Secretory epithelial cell marker on gastrointestinal tumors and in human secretions denned by a monoclonal antibody. Cancer Res 47:2092-2097, 1987
15. Brezicka FT, Oiling S, Nilsson O, et al: Immunohistological detection of fucosyl-GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies. Cancer Res 49:1300-1305, 1989
16. Saito H, Uchiyama K, Nakamura I, et al: J Natl Cancer Inst 80:728-734, 1988
17. Franklin WA, Waintrub M, Edwards D, et al: New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Intl J Cancer 8 (suppl) :89-95, 1994
18. Danto SI, Zabski SM, Crandall ED: Late appearance of a type I alveolar epithelial cell marker during fetal rat lung development. Histochemistry 102:297-304, 1994
19. Stevens PA, Wissel H, Sieger D, et al: Identification of a new surfactant protein A binding protein at the cell membrane of rat type II pneumocytes. Biochem J 308:77-81, 1995
20. Pinnaduwage P, Huang L: Stable target-sensitive immunoliposomes. Biochemistry 31:2850-2855, 1992
21. Holmberg E, Maruyama K, Litzinger DC, et al: Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions. Biochem Biophys Res Comm 165:1272-1287, 1989
22. Buchsbaum DJ, Langmuir VK, Wessels BW: Experimental radioimmunotherapy. Med Phys 20:551-567, 1993
23. Litzinger DC, Huang L: Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochem Biophys Acta 1113:201-207, 1992
24. Welsh MJ, Tsui LC, Boat TF, et al: Cystic fibrosis, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw-Hill, 1995
25. Collins FS: Cystic fibrosis: Molecular biology and therapeutic implications. Science 256:774-779, 1992
26. Smith JJ, Travis SM, Greenberg EP, et al: Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236, 1996
27. Johnson LG: Gene therapy for cystic fibrosis. Chest 107 (suppl):77S-83S, 1995
28. Knowles MR, Hohneker KW, Zhou Z, et al: A controlled study of adenoviralvector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831, 1995